CJC-DAC / IPA Blend

CJC-DAC / IPA Blend is a dual-peptide blend containing CJC-1295 with DAC and ipamorelin intended for controlled laboratory work. It is studied in experimental systems involving extended GHRH- and ghrelin-receptor signaling within GH/IGF-1-axis models. Descriptions of research pathways do not establish safety, effectiveness, or suitability for human or veterinary use.

Research areas include:
• Long-acting GHRH-receptor signaling
• Ghrelin-receptor secretagogue response
• GH and IGF-1 biomarker models
• Two-component pharmacokinetic and stability research

Research limitations and safety:
• Blend names and ratios are not standardized. Every formulation requires explicit ingredient amounts plus independent identity, purity, compatibility, and stability verification. Published or regulatory sources identify material safety uncertainties or adverse signals requiring particular caution.
• No dosing, administration, or therapeutic-use guidance is provided.

being sold for research only.